HK1160385A1 - 製備穩定的單層脂質體混懸液的組合物和方法 - Google Patents

製備穩定的單層脂質體混懸液的組合物和方法

Info

Publication number
HK1160385A1
HK1160385A1 HK12100802.4A HK12100802A HK1160385A1 HK 1160385 A1 HK1160385 A1 HK 1160385A1 HK 12100802 A HK12100802 A HK 12100802A HK 1160385 A1 HK1160385 A1 HK 1160385A1
Authority
HK
Hong Kong
Prior art keywords
composition
preparing stable
liposomal suspension
unilamellar liposomal
stable unilamellar
Prior art date
Application number
HK12100802.4A
Other languages
English (en)
Inventor
Penelope M Anderson
Original Assignee
Access Business Group Int Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Access Business Group Int Llc filed Critical Access Business Group Int Llc
Publication of HK1160385A1 publication Critical patent/HK1160385A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/26—Optical properties
    • A61K2800/262—Transparent; Translucent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/413—Nanosized, i.e. having sizes below 100 nm

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Nanotechnology (AREA)
  • Emergency Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medical Informatics (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Colloid Chemistry (AREA)
HK12100802.4A 2008-10-03 2012-01-27 製備穩定的單層脂質體混懸液的組合物和方法 HK1160385A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/245,528 US9445975B2 (en) 2008-10-03 2008-10-03 Composition and method for preparing stable unilamellar liposomal suspension
PCT/US2009/057820 WO2010039490A2 (en) 2008-10-03 2009-09-22 Composition and method for preparing stable unilamellar liposomal suspension

Publications (1)

Publication Number Publication Date
HK1160385A1 true HK1160385A1 (zh) 2012-08-17

Family

ID=42074101

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12100802.4A HK1160385A1 (zh) 2008-10-03 2012-01-27 製備穩定的單層脂質體混懸液的組合物和方法

Country Status (7)

Country Link
US (1) US9445975B2 (zh)
JP (1) JP5706326B2 (zh)
KR (1) KR101705912B1 (zh)
CN (1) CN102170853B (zh)
HK (1) HK1160385A1 (zh)
TW (1) TWI537009B (zh)
WO (1) WO2010039490A2 (zh)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120100207A1 (en) * 2009-07-02 2012-04-26 Konica Minolta Holdings, Inc. Process for producing liposomes by two-step emulsification method utilizing outer aqueous phase containing specific dispersing agent, process for producing liposome dispersion or dry powder thereof using the process for producing liposomes, and liposome dispersion or dry powder thereof produced thereby
FR2950807B1 (fr) * 2009-10-06 2012-02-03 Lvmh Rech Composition cosmetique contenant des liposomes encapsules dans un compose oxazolidin-2-one
WO2011123525A1 (en) * 2010-04-01 2011-10-06 The Regents Of The University Of California Forming an artificial cell with controlled membrane composition, asymmetry and contents
DE202012012801U1 (de) * 2011-05-10 2014-02-17 Mary Kay Inc. Kosmetikzusammensetzungen
FR2978661B1 (fr) * 2011-08-03 2017-12-22 Beaute Luxe Simplicite Composition lipidique pour application cosmetique
US9375388B2 (en) 2011-09-23 2016-06-28 Indian Institute Of Technology, Bombay Nanoparticle based cosmetic composition
EP2805144A4 (en) * 2012-01-17 2015-09-09 Scripps Research Inst PREPARATION OF ORDERED SAMPLE SETS ON A GRID FOR ELECTRONIC MICROSCOPY
WO2013109406A1 (en) * 2012-01-17 2013-07-25 The Scripps Research Institute Apparatus and method for producing specimens for electron microscopy
JP2016527254A (ja) * 2013-07-25 2016-09-08 リー エバーティング，シェリル 表皮修復のための製剤
US8986732B2 (en) 2013-08-12 2015-03-24 Helix Biopharma Corporation Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery
US10159646B2 (en) * 2013-08-12 2018-12-25 Altum-Avro Pharma Partnership Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery
JP6444802B2 (ja) * 2015-04-30 2018-12-26 上野製薬株式会社 液体防腐剤組成物およびその製造方法
BE1024190B1 (nl) * 2016-11-04 2017-12-05 Yun NV Microbioom-veilige cosmetische reinigingssamenstellingen
WO2018123002A1 (ja) * 2016-12-28 2018-07-05 小林製薬株式会社 外用組成物
JP6853979B2 (ja) * 2017-03-17 2021-04-07 学校法人帝京大学 プラスマローゲン含有水性液
CN110891610B (zh) * 2017-03-23 2024-03-01 脂类系统股份公司 亲水性化合物在单层脂质体中的高效包封
US10722465B1 (en) * 2017-12-08 2020-07-28 Quicksilber Scientific, Inc. Transparent colloidal vitamin supplement
KR101931920B1 (ko) 2018-10-02 2018-12-21 주식회사 카버코리아 데이노코쿠스 추출물을 함유한 나노 베지클, 이의 제조방법, 및 이를 함유한 화장료 조성물
EP3893832A1 (en) 2018-12-14 2021-10-20 Mary Kay, Inc. Cosmetic compositions
US11291702B1 (en) 2019-04-15 2022-04-05 Quicksilver Scientific, Inc. Liver activation nanoemulsion, solid binding composition, and toxin excretion enhancement method
TWI712403B (zh) * 2019-08-26 2020-12-11 長庚大學 水膠敷材
JP2021098668A (ja) * 2019-12-23 2021-07-01 株式会社アイ・ティー・オー 細胞送達用キャリア
JPWO2022102730A1 (zh) * 2020-11-13 2022-05-19
CN112957277B (zh) * 2021-02-06 2022-06-10 武汉百思凯瑞生物科技有限公司 一种多重透明质酸纳米组合物及其制备方法和应用
CN113230186B (zh) * 2021-05-26 2023-03-17 广州欧正化妆品技术研究院有限公司 高稳定性保湿脂质体乳液及其制备方法
KR102333531B1 (ko) * 2021-08-02 2021-12-01 이석연 베타-시토스테롤을 고함량 포함하는 피부 장벽 개선용 화장료 조성물
IT202200007817A1 (it) * 2022-04-20 2023-10-20 Intercos Italiana “Concentrato vescicolare per prodotti cosmetici, prodotti cosmetici contenenti detto concentrato vescicolare metodo per la loro produzione”
CN115300580A (zh) 2022-04-25 2022-11-08 捷通国际有限公司 用于抑制晚期糖化终产物的组合物和方法
CN114886938B (zh) * 2022-05-05 2023-07-18 尼腾(广州)生物科技有限公司 一种适用于银屑病的复合组合物及其制备方法

Family Cites Families (191)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH588887A5 (zh) 1974-07-19 1977-06-15 Battelle Memorial Institute
US4897308A (en) 1975-06-30 1990-01-30 L'oreal Compositions comprising aqueous dispersions of lipid spheres
LU76148A1 (zh) 1976-11-08 1978-07-10
JPS5782310U (zh) 1980-11-06 1982-05-21
JPS5782310A (en) * 1980-11-11 1982-05-22 Tanabe Seiyaku Co Ltd Production of liposome preparation
JPS607932Y2 (ja) 1980-12-18 1985-03-19 川崎重工業株式会社 自動２輪車のラジエタ−
JPS607932A (ja) * 1983-06-29 1985-01-16 Dai Ichi Seiyaku Co Ltd リポソーム懸濁液およびその製法
US4708816A (en) 1984-01-27 1987-11-24 The Clorox Company Bleach composition containing controlled density capsules
US5008050A (en) 1984-06-20 1991-04-16 The Liposome Company, Inc. Extrusion technique for producing unilamellar vesicles
CA1264668A (en) 1984-06-20 1990-01-23 Pieter R. Cullis Extrusion techniques for producing liposomes
FR2571963B1 (fr) 1984-10-24 1987-07-10 Oreal Composition a usage cosmetique ou pharmaceutique contenant des niosomes et au moins un polyamide hydrosoluble et procede de preparation de cette composition.
US4753750A (en) 1984-12-31 1988-06-28 Delaware Liquid laundry detergent composition and method of use
US4830858A (en) * 1985-02-11 1989-05-16 E. R. Squibb & Sons, Inc. Spray-drying method for preparing liposomes and products produced thereby
US5041278A (en) 1985-10-15 1991-08-20 The Liposome Company, Inc. Alpha tocopherol-based vesicles
AU599456B2 (en) 1986-11-28 1990-07-19 Liposome Company, Inc., The Phospholipid composition
US5166139A (en) 1987-02-26 1992-11-24 Indena, S.P.A. Complexes of saponins and their aglycons with phospholipids and pharmaceutical and cosmetic compositions containing them
US5176713A (en) 1987-07-15 1993-01-05 Colgate-Palmolive Co. Stable non-aqueous cleaning composition method of use
US4931195A (en) 1987-07-15 1990-06-05 Colgate-Palmolive Company Low viscosity stable non-aqueous suspension containing organophilic clay and low density filler
US4828723A (en) 1987-07-15 1989-05-09 Colgate-Palmolive Company Stable non-aqueous suspension containing organophilic clay and low density filler
ATE109970T1 (de) 1987-09-03 1994-09-15 Univ Georgia Res Found Cyclosporin-augenmittel.
EP0319638A1 (en) 1987-12-08 1989-06-14 Estee Lauder Inc. Liposome containing cosmetic and pharmaceutical compositions and methods for utilizing such compositions
JP2643217B2 (ja) 1988-01-22 1997-08-20 エーザイ株式会社 脂溶性物質水性液
FR2645741B1 (fr) 1989-03-20 1995-06-23 Dior Christian Parfums Procede pour fixer un produit sur la membrane d'un keratinocyte au moyen d'une liaison ligand-recepteur, procede de preparation d'un tel produit, produit obtenu, composition cosmetique ou pharmaceutique le contenant et son procede de preparation
US5364632A (en) 1989-04-05 1994-11-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Medicinal emulsions
FR2650953B1 (fr) 1989-08-17 1991-12-06 Lvmh Rech Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant au moins un derive de labdane, ou un extrait de plante en contenant; composition cosmetique ou pharmaceutique, notamment dermatologique l'incorporant
US5258197A (en) 1989-09-20 1993-11-02 Nabisco, Inc. Reduced calorie triglyceride mixtures
DE3934656A1 (de) 1989-10-13 1991-04-18 Schering Ag Verfahren zur herstellung von waessrigen dispersionen
FR2654935B1 (fr) 1989-11-28 1994-07-01 Lvmh Rech Utilisation de xanthines, eventuellement incorporees dans des liposomes, pour favoriser la pigmentation de la peau ou des cheveux.
US5733572A (en) 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
FR2657526B1 (fr) 1990-01-31 1994-10-28 Lvmh Rech Utilisation d'un phosphate d'alpha-tocopherol, ou de l'un de ses derives, pour la preparation de compositions cosmetiques, dermatologiques, ou pharmaceutiques; compositions ainsi obtenues.
US5741513A (en) 1990-02-08 1998-04-21 A. Natterman & Cie. Gmbh Alcoholic aqueous gel-like phospholipid composition, its use and topical preparations containing it
US5204105A (en) 1990-04-10 1993-04-20 Chanel, Inc. Cosmetic composition
ATE138803T1 (de) 1990-07-31 1996-06-15 Liposome Co Inc Anhäufung von aminosäuren und peptiden in liposomen
IS1685B (is) 1990-12-11 1998-02-24 Bracco International B.V. Aðferð við að búa til fitukúlur (liposomes) sem eru gæddar auknum hæfileika til að draga í sig og halda í sér aðskotaefnum
US5498420A (en) 1991-04-12 1996-03-12 Merz & Co. Gmbh & Co. Stable small particle liposome preparations, their production and use in topical cosmetic, and pharmaceutical compositions
FR2676649B1 (fr) 1991-05-22 1994-02-25 Lvmh Recherche Composition cosmetique ou pharmaceutique, notamment dermatologique, destinee a favoriser la pigmentation de la peau ou des cheveux, contenant un extrait de cyperus et son procede de fabrication.
EP0532465B1 (de) 1991-09-13 2002-07-10 Pentapharm A.G. Proteinfraktion zur kosmetischen und dermatologischen Pflege der Haut
EP0633875B1 (en) 1992-04-03 1997-01-02 Gist-Brocades N.V. Selective n-acylation of amino alcohols
JPH067932A (ja) * 1992-05-21 1994-01-18 Okuoka Seisakusho:Kk グレーチングの製造方法
IT1257543B (it) * 1992-05-26 1996-01-30 Cselt Centro Studi Lab Telecom Sistema di demultiplazione ottica.
CA2146963A1 (en) 1992-10-16 1994-04-28 Andreas Sachse Process and device for producing liquid, dispersed systems
US6764693B1 (en) 1992-12-11 2004-07-20 Amaox, Ltd. Free radical quenching composition and a method to increase intracellular and/or extracellular antioxidants
CA2153780C (en) 1993-01-15 2004-04-13 Micro Vesicular Systems, Inc. Method of inhibiting viral reproduction
US6387373B1 (en) 1993-01-15 2002-05-14 Novavax, Inc. Vaccines containing paucilsmellar lipid vesicles as immunological adjuvants
US5358752A (en) 1993-02-23 1994-10-25 Norac Technologies Inc. Skin care composition
DE69424279T2 (de) 1993-02-26 2000-12-21 Fountain Pharm Inc Abgabesystem für impfstoffe und lagerstabile vorstufenlösung zur nachträglichen verkapselung von aktivstoffen
DE59406065D1 (de) 1993-03-24 1998-07-02 Ciba Geigy Ag Verfahren zur Herstellung einer Liposomendispersion im Hochdruckbereich
US5516793A (en) 1993-04-26 1996-05-14 Avon Products, Inc. Use of ascorbic acid to reduce irritation of topically applied active ingredients
DE69425940T2 (de) 1993-05-06 2001-01-18 Dsm Nv Enzymatische synthese von ceramiden und hybrid-ceramiden
US5310556A (en) 1993-06-09 1994-05-10 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic composition
US5853755A (en) 1993-07-28 1998-12-29 Pharmaderm Laboratories Ltd. Biphasic multilamellar lipid vesicles
JPH08505882A (ja) 1993-11-05 1996-06-25 アムジエン・インコーポレーテツド リポソーム調製法及び物質のカプセル化方法
CA2126648C (en) 1993-11-09 2000-10-10 Tomas De Paoli Liposomes containing bioavailable iron (ii) and method for obtaining them
US5368857A (en) 1993-11-15 1994-11-29 Elizabeth Arden Company, Division Of Conopco, Inc. Ceramide cosmetic compositions
US7083572B2 (en) 1993-11-30 2006-08-01 Bristol-Myers Squibb Medical Imaging, Inc. Therapeutic delivery systems
FR2714598B1 (fr) 1993-12-30 1996-02-09 Oreal Composition amincissante à deux types de liposomes pour traitement topique, son utilisation.
US5776488A (en) 1994-03-11 1998-07-07 Yoshitomi Pharmaceutical Industries, Ltd. Liposome preparation
FR2719219B1 (fr) 1994-05-02 1996-06-21 Rocher Yves Biolog Vegetale Composition cosmétique ou pharmaceutique à usage topique comprenant des vésicules lipidiques.
US5736121A (en) 1994-05-23 1998-04-07 Imarx Pharmaceutical Corp. Stabilized homogenous suspensions as computed tomography contrast agents
US6017558A (en) 1994-06-17 2000-01-25 Nestec S.A. Incorporation of a water-soluble active principle in a lipid
WO1995035157A1 (fr) 1994-06-20 1995-12-28 Nippon Shinyaku Co., Ltd. Procede de fabrication d'emulsion et emulsificateur
DE4430592A1 (de) 1994-08-20 1996-02-22 Max Delbrueck Centrum Liposomale Zubereitung, ihre Herstellung und ihre Verwendung
US5702722A (en) 1994-09-30 1997-12-30 Bracco Research S.A. Liposomes with enhanced entrapment capacity, method and use
US5693677A (en) 1994-09-30 1997-12-02 Gist-Brocades N.V. Ceramide 3 derivatives based on monounsaturated fatty acids
CA2148202A1 (en) 1994-10-20 1996-04-21 Frederick H. Burmeister Liposome delivery of active ingredients to enhance tanning and repair uv damage
HU223475B1 (hu) 1994-10-24 2004-07-28 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Selegilint tartalmazó liposzoma-készítmény és eljárás ennek előállítására
EP0741562A1 (en) 1994-11-28 1996-11-13 Gist-Brocades B.V. Topical application of ceramides
US5716625A (en) 1994-12-21 1998-02-10 Cosmederm Technologies Formulations and methods for reducing skin irritation
US5560917A (en) 1995-02-01 1996-10-01 Maybelline Intermediate Company Cosmetic makeup composition
US5523090A (en) 1995-02-24 1996-06-04 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Skin treatment composition
US5945409A (en) 1995-03-10 1999-08-31 Wilson T. Crandall Topical moisturizing composition and method
US6271001B1 (en) 1995-03-23 2001-08-07 Bio Polymers Pty. Ltd. Cultured plant cell gums for food, pharmaceutical, cosmetic and industrial applications
WO1996037192A1 (en) 1995-05-26 1996-11-28 Vesifact Ag Pharmaceutical and cosmetic compositions containing sphingo- and glycolipids
AU6698196A (en) 1995-08-15 1997-03-12 Universite Libre De Bruxelles Liposomes preparation method and plant
US6120794A (en) 1995-09-26 2000-09-19 University Of Pittsburgh Emulsion and micellar formulations for the delivery of biologically active substances to cells
EP0863748A4 (en) 1995-10-11 1999-11-03 Kevin Jon William LIPOSOMAL COMPOSITIONS AND METHODS OF USE
US6183774B1 (en) 1996-01-31 2001-02-06 Collaborative Laboratories, Inc. Stabilizing vitamin A derivatives by encapsulation in lipid vesicles formed with alkylammonium fatty acid salts
US5723059A (en) 1996-05-21 1998-03-03 The United States Of America As Represented By The Secretary Of The Air Force Fluid density adjustment for functional fluids
US7384923B2 (en) 1999-05-14 2008-06-10 Lipoxen Technologies Limited Liposomes
KR19980067138A (ko) 1997-01-31 1998-10-15 박원훈 유전자 또는 생물학적 활성 약물을 세포내로 효과적으로 전달하는 지방 유제 및 그것의 제조방법
US6034908A (en) 1997-02-11 2000-03-07 Artisan Components, Inc. Sense amplifying methods and sense amplification integrated devices
US5962015A (en) 1997-05-02 1999-10-05 Kobo Products S.A.R.L. Stabilized liposomes
US5747006A (en) 1997-05-14 1998-05-05 Amway Corporation Skin whitener composition containing acerola cherry fermentate
US6074647A (en) 1998-04-14 2000-06-13 Amway Corporation Method of increasing skin cell renewal rate using acerola cherry fermentate
US6033708A (en) 1997-09-30 2000-03-07 The United States Of America As Represented By The Secretary Of The Navy Method for producing sterile filterable liposome dispersion
DE19752893A1 (de) 1997-11-28 1999-08-12 Henkel Kgaa Cyanacrylat-Klebstoff mit einem Ester-Zusatz
WO1999029293A1 (en) 1997-12-05 1999-06-17 Dsm N.V. Compositions comprising a combination of a free sphingoid base and a ceramide and uses thereof
US6350458B1 (en) 1998-02-10 2002-02-26 Generex Pharmaceuticals Incorporated Mixed micellar drug deliver system and method of preparation
GB9813100D0 (en) 1998-06-18 1998-08-19 Secr Defence Method of forming liposomes
US6290987B1 (en) 1998-09-27 2001-09-18 Generex Pharmaceuticals, Inc. Mixed liposome pharmaceutical formulation with amphiphiles and phospholipids
US6136330A (en) 1998-10-30 2000-10-24 Colgate Palmolive Company Composition
US6521237B2 (en) 1998-11-12 2003-02-18 Johnson & Johnson Consumer Companies, Inc. Skin care composition
ATE397488T1 (de) 1998-11-13 2008-06-15 Heriot William A Vorrichtung zur herstellung von liposomen
JP2002535268A (ja) 1999-01-25 2002-10-22 オプティム セラピューティクス， インコーポレイテッド リポソーム処方物
GB9902527D0 (en) 1999-02-04 1999-03-24 Phares Pharm Res Nv Compositions
JP2002536396A (ja) 1999-02-12 2002-10-29 ザ、プロクター、エンド、ギャンブル、カンパニー 化粧品組成物
US6630163B1 (en) 1999-04-22 2003-10-07 Howard Murad Method of treating dermatological disorders with fruit extracts
EP1183011A4 (en) 1999-05-14 2005-01-19 Esperion Luv Dev Inc METHOD FOR THE TREATMENT OF ANGINA AND / OR SIMILAR ILLNESSES AND THE MEDICINAL PRODUCTS AND KITS THEREOF
US6184247B1 (en) 1999-05-21 2001-02-06 Amway Corporation Method of increasing cell renewal rate
US6982284B1 (en) 1999-09-10 2006-01-03 Applied Genetics Incorporated Dermatics Compositions and methods for modification of skin lipid content
AU4508101A (en) 1999-11-29 2001-06-18 Collaborative Group, Ltd., The Lipid nanotubules for topical delivery
AU4508201A (en) 1999-11-29 2001-06-18 Collaborative Group, Ltd., The Sphingolipid-containing cationic liposomes for topical delivery of bioactive material including genetic material
WO2001056548A2 (en) 2000-02-04 2001-08-09 Lipoxen Technologies Limited Liposomes composition produced by a dehydration-rehydration process
US20020119188A1 (en) 2000-02-08 2002-08-29 Susan Niemiec Method of manufacturing liposomes
US6361806B1 (en) 2000-02-23 2002-03-26 Michael P. Allen Composition for and method of topical administration to effect changes in subcutaneous adipose tissue
US6545052B2 (en) 2000-05-10 2003-04-08 Fan Tech, Ltd. Methods and compositions for inhibiting free radical polymerization in skin and hair
JP2001342110A (ja) 2000-06-02 2001-12-11 Ezaki Glico Co Ltd 皮膚外用剤
US6696081B2 (en) 2000-06-09 2004-02-24 Duke University Carbohydrate based lipid compositions and supramolecular structures comprising same
AU7688301A (en) 2000-07-13 2002-01-30 Skinmedica Inc Composition for topically delivering vitamin c
US6576248B1 (en) 2000-09-11 2003-06-10 Avon Products, Inc. Pigmented vitamin C composition
US6753083B2 (en) 2000-11-06 2004-06-22 Ciba Specialty Chemicals Water Treatments Ltd. Particles
US20080124409A1 (en) 2000-11-21 2008-05-29 Access Business Group International Llc Topical Skin Compositions, Their Preparation, and Their Use
US20070003536A1 (en) 2000-11-21 2007-01-04 Zimmerman Amy C Topical skin compositions, their preparation, and their use
US20030095959A1 (en) 2000-11-21 2003-05-22 Access Business Group International Llc. Topical skin composition
US6596543B2 (en) 2001-03-22 2003-07-22 Dade Behring Inc. Use of liposomes of defined composition and size for the preparation of prothrombin time reagents
KR100695610B1 (ko) 2001-05-15 2007-03-14 주식회사 엘지생활건강 비면역성 발모성분인 [감마 히드록시 엔-메틸 엘-루신4] 사이클로스포린 유도체를 함유한 두피 및 경피용 제제 조성물
US20030206881A1 (en) 2001-05-31 2003-11-06 Peter Fussbroich Phospholipidic composition as well as the use thereof
US6759073B2 (en) 2001-07-02 2004-07-06 The Procter & Gamble Co. Compositions and methods for stabilization and enhanced viscosity
US7943067B2 (en) * 2001-08-16 2011-05-17 Polytechnic Institute Of New York University Nanogels and their production using liposomes as reactors
KR100439068B1 (ko) * 2001-09-07 2004-07-05 주식회사 코리아나화장품 레티놀을 3중으로 안정화한 화장료
FR2830195B1 (fr) 2001-10-03 2004-10-22 Sederma Sa Compositions cosmetiques et dermopharmaceutiques pour les peaux a tendance acneique
US7476400B2 (en) * 2001-11-13 2009-01-13 Ferndale Ip, Inc. High-concentration lidocaine compositions and methods for their preparation
US20030143265A1 (en) 2001-12-19 2003-07-31 Seiichi Araki Method for treatment of sepsis
IL148292A (en) 2002-02-21 2008-08-07 Shai Yarkoni Stable preparations of lupoginone and other quinazolinone derivatives
FR2836630B1 (fr) 2002-03-01 2004-07-09 Lvmh Rech Utilisation cosmetique de la phytosphingosine comme agent amincissant et compositions cosmetiques contenant de la phytosphingosine
US20040082521A1 (en) 2002-03-29 2004-04-29 Azaya Therapeutics Inc. Novel formulations of digitalis glycosides for treating cell-proliferative and other diseases
US7300670B2 (en) 2002-04-03 2007-11-27 Unilab Pharmatech, Ltd. Oral suspension formulation
US20060093661A1 (en) 2002-05-07 2006-05-04 Kapac, Llc Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs
US20030212046A1 (en) 2002-05-07 2003-11-13 Kapac, Llc Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs
US20030211139A1 (en) * 2002-05-07 2003-11-13 Thierry Legon Dispersions of lipid particles for use as therapeutic and cosmetic agents and intracellular delivery vehicles
JP3415131B1 (ja) 2002-06-03 2003-06-09 メビオファーム株式会社 リポソーム製剤
US20030232091A1 (en) 2002-06-17 2003-12-18 Adi Shefer Stabilized retinol for cosmetic dermatological, and pharmaceutical compositions, and use thereof
DE10231468A1 (de) 2002-07-08 2004-02-26 Coty B.V. Anti-Hautalterungskosmetikum
US7226583B2 (en) 2002-08-12 2007-06-05 Hair Systems, Inc. Composition containing leukocyte extract for the whitening or lightening of skin
DE10243626A1 (de) 2002-09-19 2004-04-01 Henkel Kgaa Haarbehandlungsmittel enthaltend eine Wirkstoffkombination mit Liposomen
US7785623B2 (en) 2002-10-01 2010-08-31 Keller Brian C Compositions and methods useful for the reduction of fine lines and wrinkles
KR100489701B1 (ko) 2002-10-09 2005-05-16 주식회사 태평양 고농도의 트리터페노이드를 함유하는 미소화 리포좀 및 그제조방법
US6926886B2 (en) 2002-10-31 2005-08-09 Johnson & Johnson Consumer Companies, Inc. Compositions for darkening the skin and/or hair
EP1585504A4 (en) 2002-11-06 2009-07-15 Azaya Therapeutics Inc LIPOSOMAL PREPARATIONS OF PHARMACEUTICAL AGENTS STABILIZED BY PROTEINS
US20040224010A1 (en) 2002-11-15 2004-11-11 Optime Therapeutics, Inc. Ophthalmic liposome compositions and uses thereof
US7169382B2 (en) 2003-01-30 2007-01-30 L'oreal Reconstructed epidermis/skin equivalent comprising a ceramide 7 and /or 5.5 and lipid lamellar vesicular compositions comprising ceramide 7 and/or 5.5 compounds
MXPA05008489A (es) 2003-02-11 2005-10-18 Neopharm Inc Procedimiento de fabricacion para preparaciones liposomicas.
AU2004212944B2 (en) * 2003-02-14 2008-08-21 Children's Hospital & Research Center At Oakland Lipophilic drug delivery vehicle and methods of use thereof
CA2518791A1 (en) 2003-03-11 2004-09-23 Qlt Usa Inc. Formulations for cell-schedule dependent anticancer agents
WO2004082612A2 (en) * 2003-03-14 2004-09-30 Optime Therapeutics Inc. Liposomal formulations and methods of use
EP1481663A1 (en) 2003-05-27 2004-12-01 The Procter & Gamble Company Stable cosmetic compositions comprising a self-tanning agent
WO2005000272A1 (en) 2003-06-04 2005-01-06 Isis Pharmaceuticals, Inc. Long-circulating liposomal compositions
US20050207998A1 (en) 2003-07-21 2005-09-22 Yaoping Lu Caffeine salt complexes and methods for using the same in the prevention or treatment of cancer
DE10339358A1 (de) 2003-08-27 2005-03-24 Cognis Deutschland Gmbh & Co. Kg Verwendung von Liposomen zur Ausrüstung von Fasern und Textilien
US20070003607A1 (en) 2003-09-02 2007-01-04 Vibhudutta Awasthi Neutral liposome-encapsulated compounds and methods of making and using thereof
US20050058674A1 (en) 2003-09-11 2005-03-17 Kimberly-Clark Worldwide, Inc. Moisturizing and lubricating compositions
EP1670434A4 (en) 2003-10-02 2010-06-23 Sembiosys Genetics Inc PROCESSES FOR PREPARING OILY BODIES COMPRISING ACTIVE INGREDIENTS
JP2007508320A (ja) 2003-10-10 2007-04-05 アクセス ビジネス グループ インターナショナル エルエルシー マンネンロウ（Ｒｏｓｍａｒｉｎｕｓｏｆｆｉｃｉｎａｌｉｓ）植物抽出物、センテラ（Ｃｅｎｔｅｌｌａ）、ムラサキバレンギク（Ｅｃｈｉｎａｃｅａ）又はアルピニア（Ａｌｐｉｎｉａ）植物抽出物、及びＤＮＡ修復酵素を含む組成物
US7160560B2 (en) 2003-10-23 2007-01-09 L'oreal S.A. Skin-care composition
WO2005044217A1 (en) 2003-11-11 2005-05-19 Doosan Corporation Method for preparing phytosphingosine liposome composition
CN101889981A (zh) 2003-11-20 2010-11-24 Ym生物科学有限公司 包含含有药物成分的亲脂胺的稳定脂质体组合物
EP1547674A1 (en) 2003-12-23 2005-06-29 MediGene Oncology GmbH Method for producing colloidal nanoparticles
EP1547581A1 (en) 2003-12-23 2005-06-29 Vectron Therapeutics AG Liposomal vaccine for the treatment of human hematological malignancies
TWI350183B (en) 2003-12-31 2011-10-11 Ind Tech Res Inst A liposome and a preparation method
WO2005077337A2 (en) 2004-02-05 2005-08-25 Baxter International Inc. Dispersions prepared by use of self-stabilizing agents
WO2005097069A1 (en) 2004-03-26 2005-10-20 Stiefel Laboratories, Inc. Topical skin protectant cosmetic compositions
CN1938048B (zh) 2004-03-26 2010-05-12 泰尔茂株式会社 脂质体制剂
US20050232973A1 (en) 2004-04-19 2005-10-20 Makarand Gore Systems and methods for preparation of pharmaceutical dosage using compositions containing aqueous vesicles
EP1747017B1 (en) 2004-05-10 2008-03-26 Robert F. Hofmann Use of targeted oxidative therapeutic formulation in treatment of age-related macular degeneration
FR2870741B1 (fr) 2004-05-25 2008-03-14 Coletica Sa Phase lamellaires hydratees ou liposomes, contenant une monoamine grasse ou un polymere cationique favorisant la penetration intercellulaire, et composition cosmetique ou pharmaceutique la contenant.
JP4758915B2 (ja) 2004-08-06 2011-08-31 バイオスペクトラム，インコーポレイテッド 多重層リポソームおよびその製造方法
JP5176320B2 (ja) 2004-08-11 2013-04-03 コニカミノルタエムジー株式会社 リポソーム含有製剤の製造方法
WO2006026713A2 (en) 2004-08-31 2006-03-09 Tracie Martyn International, Llc Topical benfotiamine and pyridoxamine compositions
US20060116404A1 (en) 2004-09-24 2006-06-01 Gary Robinson CAI-based systems and methods for the localized treatment of ocular and other diseases
US7192762B2 (en) 2004-11-04 2007-03-20 E. I. Du Pont De Nemours And Company Mortierella alpina glycerol-3-phosphate o-acyltransferase for alteration of polyunsaturated fatty acids and oil content in oleaginous organisms
WO2006071659A1 (en) 2004-12-29 2006-07-06 Trustees Of Boston University Delivery of h2 antagonists
US20060165641A1 (en) 2005-01-18 2006-07-27 Kumar Pillai Cosmetic compositions containing combinations of hydroxamate derivatives and antioxidants in a liposomal delivery system
US20080183250A1 (en) 2005-02-11 2008-07-31 Hanafi Tanojo Compositions and methods for treating or preventing skin inflammation via restoration of skin barrier function
US20060188559A1 (en) 2005-02-18 2006-08-24 E. T. Browne Drug Co. Topical cosmetic compositions comprising alpha arbutin
US20060228406A1 (en) 2005-03-17 2006-10-12 Invitrogen Corporation Transfection reagent for non-adherent suspension cells
US7820609B2 (en) 2005-04-13 2010-10-26 The Procter & Gamble Company Mild, structured, multi-phase personal cleansing compositions comprising density modifiers
US9968120B2 (en) 2006-05-17 2018-05-15 Dsm Nutritional Products Ag Homogenized formulations containing microcapsules and methods of making and using thereof
CA2558601A1 (en) 2005-09-14 2007-03-14 Japan Science And Technology Agency Substance carrier using hollow nanoparticle of hepatitis b virus protein and liposome, and method of introducing substance into cell
EP3015101B1 (en) 2005-10-03 2019-08-21 PINSKY, Mark A. Non-phospholipid liposomes comprising hyaluronic acid
US9265792B2 (en) 2005-11-16 2016-02-23 Patricia A. Riley Integument cell regeneration formulation
PL1957044T3 (pl) 2005-12-01 2013-11-29 Pronai Therapeutics Inc Amfoteryczny preparat liposomowy
US8323392B2 (en) 2006-02-13 2012-12-04 Eastman Kodak Company Oil-in-oil dispersions stabilized by solid particles and methods of making the same
US20090186077A1 (en) 2006-02-15 2009-07-23 Ying Jackie Y Thermo-responsive materials
JP4960004B2 (ja) 2006-04-10 2012-06-27 ポーラ化成工業株式会社 ベシクル分散剤形のユビデカレノン含有化粧料
EP3357490A1 (en) 2006-04-28 2018-08-08 Children's Hospital Medical Center Fusogenic properties of saposin c and related proteins and polypeptides for application to transmembrane drug delivery systems
WO2008039989A2 (en) 2006-09-28 2008-04-03 Transave, Inc. Formulations of dnase and methods of use thereof
PL2051691T3 (pl) 2006-10-13 2010-10-29 Evonik Degussa Gmbh Kompozycja do leczenia skóry
EP1920765A1 (en) * 2006-11-07 2008-05-14 Medigene AG Liposome preparation by single-pass process
US7824708B2 (en) * 2006-12-11 2010-11-02 Access Business Group International Llc Liposome containing cardiolipin for improvement of mitochondrial function
WO2008072507A1 (en) 2006-12-14 2008-06-19 Pola Chemical Industries Inc. Skin external preparation in the form of water-in-oil emulsion comprising ceramide
US20090162425A1 (en) * 2007-09-19 2009-06-25 University Of Tennessee Research Foundation Methods and compositions for inhibiting undesirable cellular proliferation by targeted liposome delivery of active agents

Also Published As

Publication number Publication date
WO2010039490A2 (en) 2010-04-08
KR20110073495A (ko) 2011-06-29
CN102170853B (zh) 2016-07-06
TW201018498A (en) 2010-05-16
CN102170853A (zh) 2011-08-31
KR101705912B1 (ko) 2017-02-10
WO2010039490A3 (en) 2011-03-24
US20100086573A1 (en) 2010-04-08
JP5706326B2 (ja) 2015-04-22
US9445975B2 (en) 2016-09-20
TWI537009B (zh) 2016-06-11
JP2012504620A (ja) 2012-02-23

Similar Documents

Publication Publication Date Title
HK1160385A1 (zh) 製備穩定的單層脂質體混懸液的組合物和方法
EP2123260A4 (en) LIPOSOM FORMULATION AND METHOD FOR THE PRODUCTION THEREOF
IL225961A (en) Liposomal nanoparticles and a method for their preparation
EP2343990A4 (en) ENHANCED EDIBLE COMPOSITION AND PROCESS FOR PREPARING THE SAME
IL247238A0 (en) Methods for preparing vesicles and preparations including them
ZA201006944B (en) Compositions and methods for preparing and using same
IL215059A (en) Liposome preparation that includes an arboline and a process for its preparation
ZA201203316B (en) Liposome of irinotecan or its hydrochloride and preparation method thereof
HK1156594A1 (zh) 肥料懸浮液及其製備方法
ZA201105206B (en) Crystalline forms of dimethoxy docetaxel and methods for preparing same
EP2260013A4 (en) CEROXIDE MATERIAL AND MANUFACTURING METHOD THEREFOR
EP2415464A4 (en) METHOD FOR PRODUCING A LIPOSOME COMPOSITION
HUP0800763A2 (en) Nowel piperazine salt and preparation method thereof
HK1163513A1 (zh) 囊泡製劑
PL2300489T3 (pl) Sposoby wytwarzania 17-alkinylo-7-hydroksysteroidów i związków pokrewnych
EP2329823A4 (en) METHOD FOR IMPROVING CAPACITY OF PREPARATION TO BE ABSORBED AND PREPARATION WHICH CAPACITY TO BE ABSORBED IS IMPROVED
EP2538921A4 (en) METHOD AND DEVICE FOR PRODUCING A NOVEL LIPOSOMA
TWI372666B (en) Preparing composition of silver nanowire and method for forming silver nanowire
EP2366424A4 (en) AIR-PERMEABLE STRUCTURE AND METHOD OF FORMING AIR-PERMEABLE STRUCTURE
KR101030035B9 (ko) 스피루리나를 함유하는 쌀엿강정 및 그 제조방법
EP2440041A4 (en) SUSPENSION COMPOSITION AND METHOD FOR THE PRODUCTION THEREOF
ZA201008968B (en) Styrylbenzofuran derivatives as inhibitors for beta-amyloid fibril formation and preparation method thereof
GB0803969D0 (en) Improved phospholipid and method for its production
GB0821348D0 (en) Compounds and preparation methods
GB0803968D0 (en) Improved phospholipid and method for its production